ETFs positioned on Simcere Pharmaceutical Group Limited

Name YTD change Weight AuM
+6.05% - 9,273 M€
0.00% - 67 M€
+2.38% - 37 M€
-4.74%0.92% 8 M€
-22.02%0.77% 67 M€
-23.21%0.15% 500 M€
-1.22%0.14% 74 M€
-.--%0.14% 74 M€
+13.75%0.14% 61 M€
-2.21%0.09% 337 M€
+5.31%0.09% 611 M€
-0.81%0.08% 380 M€
-1.49%0.06% 701 M€
+7.71%0.06% 26,721 M€
-1.54%0.05% 26 M€
-17.17%0.05% 476 M€
+9.92%0.03% 1,493 M€
+10.25%0.03% 223 M€
0.00%0.02% 77 M€
+1.09%0.02% 12,001 M€
+9.26%0.01% 24 M€
+14.40%0.01% 6,575 M€
+11.12%0.01% 117 M€
+6.01%0.01% 1,403 M€
+6.77%0.01% 158,599 M€
+5.15%0.01% 189 M€
+6.17%0.01% 3,276 M€
+2.05%0.01% 126,032 M€
-0.54%0.01% 1,449 M€
+11.58%0.01% 1,808 M€
+7.32%0.01% 14 M€
+8.05%0.01% 43,353 M€
+11.23%0.01% 3,282 M€
+11.34%0.01% 106 M€
+16.17%0.01% 1,628 M€
+14.76%0.01% 263 M€
+9.10%0% 19 M€
+9.89%0% 62 M€
+7.36%0% 163,510 M€
+6.98%0% 235 M€
+6.46%0% 473 M€
-0.91%0% 56 M€
Logo Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Ltd is an investment holding company primarily engaged in the research and development, manufacturing and sales of pharmaceutical products. The Company mainly operates its business through two segments. The Anti-oncology Business segment is mainly engaged in the research and development, manufacturing, sales and commercialization of anti-oncology pharmaceuticals. The Other Pharmaceutical Business segment is mainly engaged in the research and development, manufacturing, sales and commercialization of pharmaceuticals with focus on the multiple therapeutic areas including neuroscience, autoimmune and anti-infection. The Company is also engaged in providing rendering commercialization service of pharmaceutical products. The Company mainly conducts its business in the domestic market.
Employees
7,064
  1. Stock Market
  2. Stocks
  3. 2096 Stock
  4. ETFs Simcere Pharmaceutical Group Limited